CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-07 | CANNON JAMES ANTHONY Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2019-01-06 | Lafond Kevin G SVP, Treasurer & CAO | Grant or award | +37,122 | 85,555 | ||
| 2019-01-06 | Lafond Kevin G SVP, Treasurer & CAO | Grant or award · Employee Stock Option (right to buy) | +58,536 | 58,536 | ||
| 2019-01-06 | Hadfield Robert General Counsel and Secretary | Grant or award | +117,572 | 117,572 | ||
| 2019-01-06 | Hadfield Robert General Counsel and Secretary | Grant or award · Employee Stock Option (right to buy) | +185,391 | 185,391 | ||
| 2019-01-06 | Cooper Laurence James Neil Chief Executive Officer | Grant or award | +337,266 | 1,518,075 | ||
| 2019-01-06 | Cooper Laurence James Neil Chief Executive Officer | Grant or award | +446,428 | 1,964,503 | ||
| 2019-01-06 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −165,178 | $2.24 | $370K | 1,799,325 |
| 2019-01-06 | Cooper Laurence James Neil Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +531,813 | 531,813 | ||
| 2019-01-06 | MAUNEY DAVID M MD President | Grant or award | +159,010 | 217,672 | ||
| 2019-01-06 | MAUNEY DAVID M MD President | Grant or award · Employee Stock Option (right to buy) | +250,733 | 250,733 | ||
| 2018-12-31 | Tarriff Scott Director | Grant or award · Stock Option (right to buy) | +126,700 | 126,700 | ||
| 2018-12-31 | Pagan Douglas W. Director | Grant or award | +40,107 | 40,107 | ||
| 2018-12-31 | Pagan Douglas W. Director | Grant or award · Stock Option (right to buy) | +63,350 | 63,350 | ||
| 2018-12-31 | Lafond Kevin G SVP, Treasurer & CAO | Shares withheld for taxes | −9,334 | $1.87 | $17K | 48,433 |
| 2018-12-31 | Ezickson Elan Director | Grant or award | +80,214 | 80,214 | ||
| 2018-12-31 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −16,156 | $1.87 | $30K | 1,180,809 |
| 2018-12-31 | CANNON JAMES ANTHONY Director | Grant or award · Stock Option (right to buy) | +126,700 | 126,700 | ||
| 2018-12-31 | Braunstein Scott Director | Grant or award · Stock Option (right to buy) | +126,700 | 126,700 | ||
| 2018-12-30 | Lafond Kevin G SVP, Treasurer & CAO | Shares withheld for taxes | −13,100 | $1.66 | $22K | 57,767 |
Page 10 of 16 · 304 trades